The yin and yang of immunosuppression with inhaled corticosteroids in asthma and COPD

P. Barnes (London, United Kingdom)

Source: Virtual Congress 2021 – Pharmacology of lung immune responses: which pathways to target!
Session: Pharmacology of lung immune responses: which pathways to target!
Session type: Symposium
Number: 2716

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Barnes (London, United Kingdom). The yin and yang of immunosuppression with inhaled corticosteroids in asthma and COPD. Virtual Congress 2021 – Pharmacology of lung immune responses: which pathways to target!

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Inhaled corticosteroids in the treatment of acute asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 305s
Year: 2002

Inhaled corticosteroids and hospitalisation due to exacerbation of COPD
Source: Eur Respir J 2003; 22: 286-289
Year: 2003



Effects of inhaled corticosteroids on cough in asthma patients
Source: Eur Respir J 2004; 24: Suppl. 48, 347s
Year: 2004

Inhaled steroids in exacerbations of COPD
Source: Eur Respir J 2007; 30: 398
Year: 2007


An economic evaluation of adding inhaled corticosteroids to systemic corticosteroids for treating acute asthma exacerbations
Source: International Congress 2019 – Severe acute asthma and troublesome wheezing
Year: 2019

Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids
Source: Breathe 2010; 6: 365
Year: 2010

Nonadherence with inhaled preventer therapy in severe asthmatic patients on long-term omalizumab
Source: Eur Respir J, 52 (2) 1801025; 10.1183/13993003.01025-2018
Year: 2018



The role of inhaled corticosteroids in the management of acute asthma
Source: Eur Respir J 2007; 30: 1035-1037
Year: 2007


Children with mild asthma: do they benefit from inhaled corticosteroids?
Source: Eur Respir J 2002; 20: 1470-1475
Year: 2002



Aerosolized budesonide therapy in acute moderate exacerbations of Indian asthmatics
Source: Eur Respir J 2004; 24: Suppl. 48, 343s
Year: 2004

Inhaled corticosteroid related pneumonia in real world among the patients with asthma and COPD
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017

Quintupling inhaled glucocorticoids to prevent childhood asthma exacerbations
Source: International Congress 2018 – Preventing asthma and COPD exacerbations by increasing the inhaled glucocorticoid dose
Year: 2018


Mechanism by which inhaled bronchodilators prevent exacerbations in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013


Inhaled steroids and COPD
Source: Eur Respir J 2008; 32: 523-524
Year: 2008


Pharmacogenetics of inhaled corticosteroid response in adults with asthma
Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights
Year: 2020




ERS guideline on withdrawal of inhaled corticosteroids in COPD
Source: ERS webinar 2021: ERS guideline on withdrawal of inhaled corticosteroids in COPD
Year: 2021


Inhaled corticosteroids decrease exercise-induced inflammation in patients with COPD
Source: Annual Congress 2007 - Mechanisms of exercise intolerance in cardiorespiratory disease
Year: 2007


Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids
Source: Eur Respir J, 49 (6) 1700848; 10.1183/13993003.00848-2017
Year: 2017



Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids
Source: Eur Respir J 2017; 49(1): 1600839; DOI: 10.1183/13993003.00839-2016
Year: 2017



Long-term adherence to inhaled corticosteroids and asthma control in adult-onset asthma
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020